Recombinant growth hormone therapy for X-linked hypophosphatemia in children (Q24244826)

Europe PubMed Central

title

Recombinant growth hormone therapy for X-linked hypophosphatemia in children (English)

0 references

author name string

Hui Ming Yang

1

0 references

Meng Mao

2

0 references

Fan Yang

3

0 references

Chaomin Wan

Cochrane Database of Systematic Reviews

4

0 references

publication date

24 January 2005

0 references

published in

0 references

cites work

Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

Bone Response to Phosphate Salts, Ergocalciferol, and Calcitriol in Hypophosphatemic Vitamin D-Resistant Rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

Urinary prostaglandins and the effect of indomethacin on phosphate excretion in children with hypophosphatemic rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

Dietary Phosphorus and 1,25-Dihydroxyvitamin D Metabolism: Influence of Insulin-Like Growth Factor I*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

Regulation of renal phosphate reabsorption during development: implications from a new model of growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

Stimulation of growth hormone secretion in children with X-linked hypophosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

7 January 2021

Disproportionate growth following long-term growth hormone treatment in short children with X-linked hypophosphataemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

7 January 2021

Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

7 January 2021

X-linked hypophosphatemia: effects of treatment with recombinant human growth hormone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

7 January 2021

Nephrocalcinosis and its relationship to treatment of hereditary rickets

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

7 January 2021

Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

7 January 2021

[Growth hormone treatment of familial hypophosphatemic rickets]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

7 January 2021

Increase in renal plasma flow and glomerular filtration rate during growth hormone treatment may be mediated by insulin-like growth factor I

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

7 January 2021

Effects of short-term growth hormone treatment on PTH, calcitriol, thyroid hormones, insulin and glucagon

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

7 January 2021

The effect of recombinant human growth hormone in children with X-linked hypophosphatemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

7 January 2021

Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004447.PUB2

7 January 2021